CORRECT-MRD I: A clinical validation study to predict recurrence in stage II-III colorectal cancer (CRC) using a bespoke circulating tumor DNA (ctDNA) assay to detect molecular residual disease (MRD).

Autor: Tsukada, Yuichiro, Sagawa, Tamotsu, Srinivasan, Gopalakrishnan, Hubert, Ayala, Purim, Ofer, Semenisty, Valeriya, Lo, Nangi, Mondello, Giuseppe, Cubillo Gracian, Antonio, Marti, Tara, Subramaniam, Somasundaram, Palomares, Melanie R., Baehner, Frederick, de Jong, Floris A, Kerr, David James, Yoshino, Takayuki
Zdroj: Journal of Clinical Oncology; 2024 Supplement, Vol. 42, pTPS98-TPS98, 48p
Databáze: Supplemental Index